Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Ruth Oltenfreiter

Awards & Distinctions

32 Results

2011

Intra-arterial treatment with 90Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital

Bieke LambertEMIEL STURMJeroen MertensRuth OltenfreiterPeter SmeetsRoberto TroisiHans Van VlierbergheLuc Defreyne

A1 Journal Article in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

2010

In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells

CHRISTEL VANGESTELMarc PeetersRuth OltenfreiterYves D'AsselerSteven StaelensMagali Van SteenkisteJan PhilippéDennis KustersChris ReutelingspergerNancy Van Damme et al.

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent

Magali Van SteenkisteRuth OltenfreiterFrancis FrankenneLiesbet VervoortErik MaquoiAgnes NoelJean-Michel FoidartChristophe Van De WieleFilip De Vos

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

2007

Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible arg424 side-chain to selectivity

Anna TochowiczKlaus MaskosRobert HuberRuth OltenfreiterVincent DiveAthanasios YiotakisMatteo ZandaWolfram BodePeter Goettig

A1 Journal Article in JOURNAL OF MOLECULAR BIOLOGY

2006

Imaging probes targeting matrix metalloproteinases

Christophe Van De WieleRuth Oltenfreiter

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

In vitro and in vivo evaluation of 123I-labeled Monoclonal Antibody against Membrane type-1 matrix metalloproteinase.

Magali Van SteenkisteRuth OltenfreiterF FRANKENNEC VAN DE WIELEF DE VOSG SLEGERS

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents

Ruth OltenfreiterLudovicus StaelensVeerle KersemansBart CornelissenF FRANKENNEJM FOIDARTChristophe Van De WieleGuido Slegers

A1 Journal Article in APPLIED RADIATION AND ISOTOPES

2005

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice

Bart CornelissenVeerle KersemansLennart JansLudovicus StaelensRuth OltenfreiterT ThonissenEric AchtenGuido Slegers

A1 Journal Article in BRITISH JOURNAL OF RADIOLOGY

In vitro and in vivo evaluation of [I-123]-VEGF(165) as a potential tumor marker

Bart CornelissenRuth OltenfreiterVeerle KersemansLudovicus StaelensF FRANKENNEJM FOIDARTG SLEGERS

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies

Ludovicus StaelensRuth OltenfreiterPETER BLANCKAERTVeerle KersemansKATIA VANDENBULCKEChristophe Van De WieleGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

Ludovicus StaelensRuth OltenfreiterFilip DumontRN WATERHOUSEK VANDENBULCKEPETER BLANCKAERTRudi DierckxGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyri din-5-one, a potential dopamine D4 ligand for SPECT studies

Ludovicus StaelensRuth OltenfreiterBart CornelissenPETER BLANCKAERTFilip De VosDieter DeforceRudi DierckxGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of Tc-99m labelled epidermal growth factor

Bart CornelissenVeerle KersemansIngrid BurvenichRuth OltenfreiterJL VANDERHEYDENO BOERMANC VANDEWIELEGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE COMMUNICATIONS

Synthesis, quality control and in vivo evaluation of [I-123] rhTIMP-2, a potential tumour-imaging agent

Ruth OltenfreiterIngrid BurvenichLudovicus StaelensA LEJEUNEF FRANKENNEJM FOIDARTGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents

Ruth OltenfreiterLudovicus StaelensUlrik HillaertA HEREMANSA NOELF FRANKENNEGuido Slegers

A1 Journal Article in APPLIED RADIATION AND ISOTOPES

Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents

Ruth OltenfreiterLudovicus StaelensS LABIEDVeerle KersemansF FRANKENNEA NOELChristophe Van De WieleGuido Slegers

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

2004

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction

Bart CornelissenKatrien RemautVeerle KersemansRuth OltenfreiterIngrid BurvenichGuido Slegers

Internalization and cellular processing of radiolabeled monoclonal antibody 14C5

Ingrid BurvenichSteve SchoonoogheRuth OltenfreiterPETER BLANCKAERTE COENEClaude CuvelierN MERTENSGuido Slegers

New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents

Ruth OltenfreiterLudovicus StaelensA LEJEUNEFilip DumontF FRANKENNEJM FOIDARTGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent

Ruth OltenfreiterLudovicus StaelensIngrid BurvenichBart CornelissenF FrankenneJM FoidartGuido Slegers

Radiosynthesis and in vivo evaluation of a carboxylic MMP inhibitor as potential SPECT tumour imaging agent

Ruth OltenfreiterLudovicus StaelensIngrid BurvenichF FrankenneJM FoidartGuido Slegers

Synthesis and assessment of [C-11]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography

Jan CourtynBart CornelissenRuth OltenfreiterMarleen VandecapelleGuido SlegersKarel Strijckmans

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

2003

Biodistribution og 123/125I-VEGF in wild type NMRI and A2058 tumor inoculated athymic mice

Bart CornelissenA JanssensVeerle KersemansRuth OltenfreiterRudi DierckxGuido Slegers

Radiosynthesis and biological activity testing of a potent gelatinase inhibitor, a new potential SPECT tumour imaging agent

Ruth OltenfreiterLudovicus StaelensA LejeuneF OlivierF FrankenneA NoelGuido Slegers

Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor

Ludovicus StaelensRuth OltenfreiterFilip DumontVeerle KersemansBart CornelissenGuido Slegers

Synthesis and in vivo evaluation of [123I]-pyrimidine-Org 13063 as potential SPECT radioligand for the 5-HT1A receptor

M VandecapelleFilip DumontRuth OltenfreiterKurt AudenaertD LeysenRudi DierckxGuido Slegers

Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies

Ludovicus StaelensFilip DumontF DE VOSRuth OltenfreiterMarleen VandecapelleRudi DierckxGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies

Ludovicus StaelensFilip DumontF DE VOSRuth OltenfreiterMarleen VandecapelleRudi DierckxGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

2002

Biological activity determination of I-BSP, a potent MMP 2 inhibitor, and its 123I tracer synthesis, World Journal of Nuclear Medicine, 2002, volume 1, supplement 2, S188

Ruth OltenfreiterLudovicus StaelensA LEJEUNEF FRANKENNERudi DierckxGuido Slegers

Synthesis and in vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential sigma receptor ligand for SPECT studies

Ludovicus StaelensFilip DumontFilip De VosRuth OltenfreiterIngeborg GoethalsRudi DierckxGuido Slegers

Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging.

C VAN DE WIELERuth OltenfreiterOlivier De WinterA SIGNOREGuido SlegersRudi Dierckx

A1 Journal Article in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

2001

Title: Synthesis, biodistribution and blocking studies in mice of a new 123I-labeled dopamine D3 antagonist Dierckx RA, Slegers G

Ludovicus StaelensFilip DumontF DEVOSRuth OltenfreiterM VANDECAPELLEIngeborg GoethalsRudi DierckxGuido Slegers